Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Interferon consensus sequence binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Mice with a null mutation of ICSBP exhibit two prominent phenotypes related to previously described activities of the IRF family. The first is enhanced susceptibility to virus infections associated with impaired production of IFN(gamma). The second is deregulated hematopoiesis in both ICSBP-/- and ICSBP+/- mice that manifests as a syndrome similar to human chronic myelogenous leukemia. The chronic period of the disease progresses to a fatal blast crisis characterized by a clonal expansion of undifferentiated cells. Normal mice injected with cells from mice in blast crisis developed acute leukemia within 6 weeks of transfer. These results suggest a novel role for ICSBP in regulating the proliferation and differentiation of hematopoietic progenitor cells.

Type

Journal article

Journal

Cell

Publication Date

18/10/1996

Volume

87

Pages

307 - 317

Keywords

Animals, Blast Crisis, Carrier Proteins, Cytotoxicity, Immunologic, Gene Expression Regulation, Hematopoiesis, Immunity, Cellular, Immunologic Deficiency Syndromes, Interferon Regulatory Factors, Interferon-alpha, Interferon-beta, Interferons, Leukemia, Experimental, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Mice, Mice, Knockout, Neoplasm Transplantation, Repressor Proteins, Syndrome, Transcription Factors, Virus Diseases